In Memorium—Martin M. Katz, PhD (1927–2017)
Marty was a prodigious and hardworking contributor to psychopharmacology. We last connected over the telephone in October 2016 when we discussed his recently written book, Clinical Trials of Antidepressants: How Changing the Model Can Uncover New, More Effective Molecules, published by Springer in February 2016. In a brief guide of 66 pages in length, Marty discusses the limitations of existing approaches to developing therapies and studying mood disorders and depression in particular. He proposes improvements in assessment tools and clinical trial protocols and argues for a better framework of understanding of depression based on current thinking about the basic biology of mood and its regulation and on what we know and do not know about the mechanisms of action of available treatments.
I never knew Marty's family, except by name: Barbara, his wife for 69 years, his daughter Nancie, and his son Pete. I am told he also had 2 granddaughters. We at the Journal of Clinical Psychopharmacology extend our deepest sympathies to the Katz family. May you always remember the love you shared and the positive times you spent together. I am certain that all of his colleagues will remember him fondly and always value his scholarship and other contributions.